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Introduction
When developing appropriate models to study tumor pro-
gression and metastasis it is essential to balance con-
cerns of tissue fidelity and physiological relevance with the
experimental accessibility of the system. Existing models
are currently being re-evaluated given an increasing
awareness of tumor complexity: in addition to the tumor
cells themselves, their neighboring cells and the surround-
ing stroma are now recognized as important regulators of
cancer progression [1]. With these added complexities in
mind, two complementary publications have recently made
a compelling case for the use of Drosophila melanogaster
in understanding tumor progression and the metastatic
process [2,3].
Previous studies using Drosophila to model cancer
revealed a collection of individual genes [e.g., discs large
(dlg), lethal giant larvae (lgl), scribble (scrib), Ras and lats]
that when homozygous mutant, resulted in tumor-like over-
proliferation in epithelial cell-rich larval imaginal discs
(reviewed in [4,5]). The papers in question both suggest
that instead of analyzing the effects of cancer-promoting
mutations in the context of an entirely mutant animal or
tissue, it would be more informative to generate mosaic
animals in which cancer-disposing mutations are intro-
duced, either alone or in specific combinations, in only a
subset of cells. Such a model would not only shed light on
the multi-step nature of tumor progression but would also
offer a reasonable approximation of the clonal nature of
human cancers.
Modeling tumor progression and metastasis
in Drosophila melanogaster
While the oncogenic properties of activated Ras are
widely appreciated (with normal cellular Ras playing a role
in proliferation, differentiation, and cell survival), the func-
tion of the epithelial cell polarity gene scrib as a tumor
suppressor is only starting to be understood. Using a
recently developed genetic engineering technique called
MARCM (mosaic analysis with a repressible cell marker)
[6], both the laboratories generated flies in which acti-
vated Ras (RasACT) and mutant scrib genes were
expressed (either alone or together) in a subset of cells
specifically in the developing eye imaginal discs. These
animals were designed such that only those cells display-
ing the engineered mutation(s) would express a green
fluorescent protein reporter gene, thereby facilitating
visual tracking of affected tissue.
Using this approach, both studies show that, analogous to
previous results in the homozygous mutant Ras tissues,
RasACT cell clones in mosaic animals display a notable
overproliferation in the eye imaginal disk of late stage
larvae. The scrib– mosaic clones, however, deviate signifi-
cantly from previous studies in homozygous animals:
instead of displaying grossly neoplastic overproliferation,
the mutant cells form small disordered foci that never
extend beyond original clonal region of expression.
Brumby and Richardson [3] elaborate upon this observa-
tion to show that overproliferation of scrib– cells is sup-
pressed in these mosaic tissues by activation of
JNK-mediated apoptotic pathways in a fashion that is not
cell autonomous but rather depends upon the presence of
surrounding wild-type cells.
When RasACT and scrib– mutations were introduced simul-
taneously in the same cells, both laboratories observed a
dramatic synergistic effect in which doubly mutant cells
experience overgrowth drastically in excess of clones dis-
playing either mutation alone. Affected cells grew such
that the eye imaginal discs expanded to many times their
normal size, eventually fusing with brain lobes and other
imaginal tissues and resulting in pupal lethality. Upon
further examination, Pagliarini and colleagues [2], showed
that in addition to this hyperproliferative effect, doubly-
mutant cells are capable of system-wide spread and
metastasis to secondary sites in the animal (including the
ventral nerve cord, the leg discs, the tracheal vasculature
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and the hemolymph). Other purely growth-promoting
mutations, in either E2F/DP or Cyclin E, could not substi-
tute for RasACT in scrib– cells nor could insults to MAPK
pathway effectors, such as PI3 kinase, Ral, Rho, Rac or
Cdc 42, however, activated Notch exerted a RasACT-like
hyperplastic effect in scrib– cells [3]. On the other hand,
when mutations in other genes known to function in the
scrib pathway (i.e., dlg,  lgl,  bazooka and  stardust) are
expressed in conjunction with RasACT, the affected tissue
still exhibits hyperproliferative and metastatic defects.
Conclusions and future directions
At the very least, the studies described by these groups
provide an elegant proof-of-principle for the multi-step
theory of cancer development in a model that also takes
into account tissue context and the clonal nature of tumor
progression. These papers clearly elucidate a combination
of mutations in Ras and scribble pathways that are, in and
of themselves, sufficient to cause tumor progression and
metastasis in flies. In doing so, they provide further proof
that maintenance of intrinsic cellular polarity can effectively
counteract the devastating proliferative defects associated
with mutations in global signaling molecules such as Ras.
Moreover, since the effects of RasACT were not mimicked
by known downstream Ras targets, these studies may
have revealed a novel cellular mechanism by which Ras
cooperates with scrib. Given the suppressive effects of
wild-type cells on scrib mutant clones, these studies serve
as a striking illustration of the importance of tissue context
in tumor progression. Understanding not only how muta-
tions affect tumor cells themselves, but also how sur-
rounding wild-type cells interact with, and possibly
protect, the tumor cells is of crucial importance in under-
standing the complexities of cancer. In the future it will be
possible to generate specific and systematic pairings
(triplings, etc.) of candidate oncogenes and tumor sup-
pressors, and to evaluate their combinatorial effects on
proliferation, apoptosis, tissue architecture and metastasis
in a physiologically relevant context. Additional
Drosophila-based screens for other genes that compli-
ment Ras and scrib pathways during tumor progression
are likely already underway.
Is Drosophila the best model for study of tumor progres-
sion and metastasis? Obviously, as with any model, this
system has its limitations. For example, fundamental differ-
ences between the hemolymph system in flies and the
mammalian vasculature and circulatory system bring into
question the utility of this organism to accurately model
metastatic processes. However, given the ease of analysis
and the genetic capabilities presented in these two
papers,  Drosophila is even more relevant to cancer
research than ever.
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